What is the ticker symbol for LivaNova?

LivaNova trades under the ticker LIVN on NASDAQ.

What sector does LivaNova operate in?

LivaNova is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze LIVN in a portfolio?

PortView shows LIVN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

LivaNova (LIVN) Stock Analysis

NASDAQHealthcareMedical - Devices

$82.69+3.15%

1-year price historyRange $49.57 – $85.33

52-week range$82.69

$48.82$85.76

What LivaNova does

LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.

Key metrics

Market cap

$4.54B

P/E (TTM)

19.64

EPS (TTM)

$4.21

Beta

0.87

Dividend yield

0.00%

Revenue / share

$26.75

50-day avg

$80.57

200-day avg

$69.38

52-week high

$85.76

52-week low

$48.82

CEO

Vladimir A. Makatsaria

ETFs linked to LIVN

Broad-market and Healthcare sector ETFs an investor holding LivaNova is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how LIVN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze LIVN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for LivaNova?: LivaNova trades under the ticker LIVN on NASDAQ.
Which exchange is LIVN listed on?: LIVN is listed on NASDAQ.
What sector does LivaNova operate in?: LivaNova is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze LIVN in a portfolio?: PortView shows LIVN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.